Brief: TransCode Therapeutics Reports Third Quarter 2022 Results, Provides Business Update
14/11/2022 22:00
Nov 14 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS REPORTS THIRD QUARTER 2022 RESULTS;
PROVIDES BUSINESS UPDATE
* TRANSCODE THERAPEUTICS INC- CASH WAS $8.8 MILLION AT
SEPTEMBER
30, 2022
Source text for Eikon: ID:nGNX1D5P0s
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors